JD Health International Past Earnings Performance
Past criteria checks 5/6
JD Health International has been growing earnings at an average annual rate of 78%, while the Consumer Retailing industry saw earnings growing at 32.5% annually. Revenues have been growing at an average rate of 24.5% per year. JD Health International's return on equity is 8.1%, and it has net margins of 7.3%.
Key information
77.98%
Earnings growth rate
78.88%
EPS growth rate
| Consumer Retailing Industry Growth | 28.31% |
| Revenue growth rate | 24.48% |
| Return on equity | 8.13% |
| Net Margin | 7.25% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Is Now The Time To Look At Buying JD Health International Inc. (HKG:6618)?
Sep 22
JD Health International Inc.'s (HKG:6618) Shareholders Might Be Looking For Exit
Aug 06JD Health International (HKG:6618) Could Be Struggling To Allocate Capital
Jul 07Is There Now An Opportunity In JD Health International Inc. (HKG:6618)?
Jun 22Is Now The Time To Put JD Health International (HKG:6618) On Your Watchlist?
May 22What JD Health International Inc.'s (HKG:6618) 37% Share Price Gain Is Not Telling You
May 07JD Health International (HKG:6618) Could Be Struggling To Allocate Capital
Mar 24
AI Integration With Jingyi Qianxun Will Improve Efficiency In Healthcare Services
Technological innovations and strategic partnerships aim to enhance customer experience, expand market share, and increase direct sales and margins.JD Health International Inc. Just Recorded A 32% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 09Calculating The Fair Value Of JD Health International Inc. (HKG:6618)
Feb 26Why Investors Shouldn't Be Surprised By JD Health International Inc.'s (HKG:6618) 27% Share Price Surge
Feb 10Should You Be Adding JD Health International (HKG:6618) To Your Watchlist Today?
Jan 24Should You Think About Buying JD Health International Inc. (HKG:6618) Now?
Jan 07JD Health International's (HKG:6618) Returns On Capital Not Reflecting Well On The Business
Dec 17Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects
Nov 04Revenue & Expenses Breakdown
How JD Health International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 65,106 | 4,721 | 11,824 | 1,422 |
| 31 Mar 25 | 61,633 | 4,441 | 11,320 | 1,376 |
| 31 Dec 24 | 58,160 | 4,162 | 10,815 | 1,330 |
| 30 Sep 24 | 56,462 | 3,390 | 10,568 | 1,293 |
| 30 Jun 24 | 54,764 | 2,618 | 10,321 | 1,255 |
| 31 Mar 24 | 54,147 | 2,380 | 10,165 | 1,241 |
| 31 Dec 23 | 53,530 | 2,142 | 10,008 | 1,226 |
| 30 Sep 23 | 53,576 | 1,930 | 9,903 | 1,212 |
| 30 Jun 23 | 53,621 | 1,718 | 9,798 | 1,197 |
| 31 Mar 23 | 50,179 | 1,049 | 9,384 | 1,132 |
| 31 Dec 22 | 46,736 | 380 | 8,969 | 1,067 |
| 30 Sep 22 | 42,003 | -7 | 8,542 | 1,023 |
| 30 Jun 22 | 37,270 | -395 | 8,114 | 978 |
| 31 Mar 22 | 33,976 | -734 | 7,911 | 935 |
| 31 Dec 21 | 30,682 | -1,074 | 7,708 | 893 |
| 30 Sep 21 | 27,463 | -6,702 | 6,799 | 813 |
| 30 Jun 21 | 24,243 | -12,331 | 5,890 | 733 |
| 31 Mar 21 | 21,813 | -14,783 | 4,923 | 671 |
| 31 Dec 20 | 19,383 | -17,234 | 3,957 | 609 |
| 30 Sep 20 | 17,007 | -11,901 | 3,346 | 537 |
| 30 Jun 20 | 14,631 | -6,567 | 2,736 | 466 |
| 31 Mar 20 | 12,737 | -3,769 | 2,389 | 402 |
| 31 Dec 19 | 10,842 | -972 | 2,042 | 338 |
| 31 Dec 18 | 8,169 | 215 | 1,458 | 218 |
| 31 Dec 17 | 5,553 | 179 | 1,002 | 123 |
Quality Earnings: 6618 has high quality earnings.
Growing Profit Margin: 6618's current net profit margins (7.3%) are higher than last year (4.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6618 has become profitable over the past 5 years, growing earnings by 78% per year.
Accelerating Growth: 6618's earnings growth over the past year (80.4%) exceeds its 5-year average (78% per year).
Earnings vs Industry: 6618 earnings growth over the past year (80.4%) exceeded the Consumer Retailing industry -6.3%.
Return on Equity
High ROE: 6618's Return on Equity (8.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 11:22 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
JD Health International Inc. is covered by 36 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiaomeng Zhuang | BofA Global Research |
| Shun Kei Law | CCB International Securities Limited |
| Hazim Bahari | CFRA Equity Research |